RxDoctor Payments Data

Juan Vilaro, MD

Cardiovascular Disease · Gainesville, FLNPI 1033316948

Payments from drug & device makers

$154,995in general payments, 2019–2025

Across 32 payments — averaging $4843.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$77K
  • AstraZeneca$48K
  • Merck$28K
  • Abiomed$469
  • Cvrx, Inc.$125
  • Medtronic$108
  • plus $126 from 4 others

What the payments were for

  • Food & beverage$88995%
  • Education$435%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis5$77,394
AstraZeneca5$48,318
Merck11$28,455
Abiomed5$469
Cvrx, Inc.1$125
Medtronic1$108
Neotract Inc.1$55
Teleflex LLC1$32
Johnson & Johnson1$28
Pfizer1$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$154,995 in reported general payments places this provider in the 90th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida

Medicare billing

Part B allowed, 2024
$121,783
Medicare patients
1,925
Services billed
3,516

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Gainesville

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →